Engy Mohamed Emad
Research Subjects
Engy Mohamed Emad has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
AbdAllah El Mamoun Sarhan
Faculty of Medicine – Zagazig University. Egypt
2 shared publicationsMohamed Hamdy Ismail
Neurology
2 shared publicationsZahraa Mahmoud Abd El-Wahed Abd Rabou
Neurology Department, Faculty of medicine, Zagazig University, Egypt
2 shared publicationsAhmed Badawy
1 shared publicationAhmed E. Badawy
Department of Neurology, Faculty of Medicine, Zagazig University, El Sharkia, Egypt
1 shared publicationAmal S. E. Elmotaym
Department of Neurology, Faculty of Medicine, Zagazig University, El Sharkia, Egypt
1 shared publication
Latest Publications
- 26 March 2025
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Plasma Fibrinogen Level as a Biomarker of Disease Activity in Multiple Sclerosis
Background; Increasing evidence suggests that fibrinogen could play a pathogenic role in multiple sclerosis (MS). This study aimed to detect the relation between the plasma fibrinogen level and MS activities either clinically or radiologically. Methods; A case control study was conducted on 62 patients of MS and clinically isolated syndrome (CIS) and 70 healthy control subjects. Plasma fibrinogen level was measured for all participants of this study. Motor disability of the patients was assessed based on Expanded Disability status Score (EDSS) and 9-Hole Peg Test (9-HPT) scale. The relationship between plasma fibrinogen levels and the presence of active lesions on brain and spinal cord MRI was analyzed. Results; Plasma fibrinogen level was significantly higher in MS patients during relapse than healthy control subjects (p<0.001). Patients with active radiological lesions were found to have a significantly higher level of plasma fibrinogen level than patients with inactive lesions (p<0.05). Patients with high fibrinogen level showed marked motor disability when compared to the patients with normal fibrinogen level regarding their scores on EDSS (p<0.001 ) and 9-HPT (p=0.05). Multivariate regression analysis showed that elevated fibrinogen level during relapse significantly and independently raises the risk of disease activity in MS patients by 4.99 times (p=0.003). Conclusions; fibrinogen level could be a practical marker for monitoring MS activity. Key words: Multiple sclerosis; fibrinogen; relapse
- 26 March 2025
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Plasma Fibrinogen Level as a Biomarker of Disease Activity in Multiple Sclerosis
Background; Increasing evidence suggests that fibrinogen could play a pathogenic role in multiple sclerosis (MS). This study aimed to detect the relation between the plasma fibrinogen level and MS activities either clinically or radiologically. Methods; A case control study was conducted on 62 patients of MS and clinically isolated syndrome (CIS) and 70 healthy control subjects. Plasma fibrinogen level was measured for all participants of this study. Motor disability of the patients was assessed based on Expanded Disability status Score (EDSS) and 9-Hole Peg Test (9-HPT) scale. The relationship between plasma fibrinogen levels and the presence of active lesions on brain and spinal cord MRI was analyzed. Results; Plasma fibrinogen level was significantly higher in MS patients during relapse than healthy control subjects (p<0.001). Patients with active radiological lesions were found to have a significantly higher level of plasma fibrinogen level than patients with inactive lesions (p<0.05). Patients with high fibrinogen level showed marked motor disability when compared to the patients with normal fibrinogen level regarding their scores on EDSS (p<0.001 ) and 9-HPT (p=0.05). Multivariate regression analysis showed that elevated fibrinogen level during relapse significantly and independently raises the risk of disease activity in MS patients by 4.99 times (p=0.003). Conclusions; fibrinogen level could be a practical marker for monitoring MS activity. Key words: Multiple sclerosis; fibrinogen; relapse
- 4 October 2024
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
The Relationship between Inflammatory Markers and Activity of Multiple Sclerosis
Background: The primary characteristics of multiple sclerosis (MS), a chronic autoimmune illness affecting the central nervous system (CNS), are inflammatory demyelination, widespread damage, and brain volume loss. These factors contribute to neurodegeneration and physical impairment. This study aimed to determine the relationship between Systemic immune inflammatory indices and Multiple sclerosis activity. Methods: This case-control study was conducted on 132 subjects; 62 clinically definite MS patients during relapse and 70 age and gender matched healthy control participants. The inflammatory markers NLR (neutrophil-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio) and C- Reactive protein (CRP) were measured for all participants and Magnetic resonance imaging (MRI) of brain and spinal cord was done for MS patients during relapse. Assessment of patients' physical disability was based on Expanded Disability Status Score (EDSS) and 9-hole Peg test (9-HPT). Results: We found that PLR and NLR were higher among MS patients than healthy control group (p≤ 0.001, p= 0.031). The best cutoff point of serum NLR to detect radiological activity in MS patients was ≥3.18 at sensitivity 70.6% and specificity 61.5% and the best cutoff point of PLR to detect radiological activity in MS patients was ≥128.155 with area under curve 0.746 (95% CI; 0.598 to 0.894) at sensitivity 76.9% and specificity 60.2%. CRP correlated significantly with 9 HPT scores (p=0.01) Conclusions: A high PLR and NLR may be promising predictive markers that detect activity of Multiple sclerosis.
- 4 October 2024
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
The Relationship between Inflammatory Markers and Activity of Multiple Sclerosis
Background: The primary characteristics of multiple sclerosis (MS), a chronic autoimmune illness affecting the central nervous system (CNS), are inflammatory demyelination, widespread damage, and brain volume loss. These factors contribute to neurodegeneration and physical impairment. This study aimed to determine the relationship between Systemic immune inflammatory indices and Multiple sclerosis activity. Methods: This case-control study was conducted on 132 subjects; 62 clinically definite MS patients during relapse and 70 age and gender matched healthy control participants. The inflammatory markers NLR (neutrophil-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio) and C- Reactive protein (CRP) were measured for all participants and Magnetic resonance imaging (MRI) of brain and spinal cord was done for MS patients during relapse. Assessment of patients' physical disability was based on Expanded Disability Status Score (EDSS) and 9-hole Peg test (9-HPT). Results: We found that PLR and NLR were higher among MS patients than healthy control group (p≤ 0.001, p= 0.031). The best cutoff point of serum NLR to detect radiological activity in MS patients was ≥3.18 at sensitivity 70.6% and specificity 61.5% and the best cutoff point of PLR to detect radiological activity in MS patients was ≥128.155 with area under curve 0.746 (95% CI; 0.598 to 0.894) at sensitivity 76.9% and specificity 60.2%. CRP correlated significantly with 9 HPT scores (p=0.01) Conclusions: A high PLR and NLR may be promising predictive markers that detect activity of Multiple sclerosis.
- 27 June 2024
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Predictors of Seizure Recurrence after Antiepileptic Drugs Withdrawal: A prospective study in Zagazig University Hospitals
; Background: Relapsing seizures following discontinuation of anti-seizure drugs (ASDs) has been the focus of several researches in the recent years. This research aimed to identify the predictive factors of seizure recurrence after anti-seizure drugs withdrawal among epileptic patients who had achieved two years seizures remission. Methods: A total of 60 epileptic patients who had achieved two years seizures remission and began ASDs withdrawal were followed prospectively for one year. The patients were divided into two groups; patients with and without relapsed seizures. Clinical and demographic details were recorded. National Hospital Seizure Severity Scale (NHS3) was used to assess the severity of epilepsy. Regular Electroencephalogram (EEG) monitoring was done. Anxiety and depressive symptoms were assessed by using generalized anxiety disorder 7 (GAD7) and Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) scales respectively. Results: Risk of post-withdrawal relapsed seizures increased with; history of status epilepticus (p=0.002), focal seizures (p=0.005), late remission of initial epileptic seizures (p=0.002), delay of ASD therapy (p<0.001), Poly-therapy (p<0.001), post-withdrawal epileptiform EEG (p<0.001), high NHS3,GAD7, NDDI-E scores (p<0.001) Conclusion: Risk of relapsing seizures after ASDs withdrawal during the first year was 60%. The decision to withdraw ASDs necessitates individual evaluation of each case with accurate assessment of risk factors associating with relapsed seizures. Keywords: Relapsed seizures, Predictors, Drug withdrawal
- 27 June 2024
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Predictors of Seizure Recurrence after Antiepileptic Drugs Withdrawal: A prospective study in Zagazig University Hospitals
; Background: Relapsing seizures following discontinuation of anti-seizure drugs (ASDs) has been the focus of several researches in the recent years. This research aimed to identify the predictive factors of seizure recurrence after anti-seizure drugs withdrawal among epileptic patients who had achieved two years seizures remission. Methods: A total of 60 epileptic patients who had achieved two years seizures remission and began ASDs withdrawal were followed prospectively for one year. The patients were divided into two groups; patients with and without relapsed seizures. Clinical and demographic details were recorded. National Hospital Seizure Severity Scale (NHS3) was used to assess the severity of epilepsy. Regular Electroencephalogram (EEG) monitoring was done. Anxiety and depressive symptoms were assessed by using generalized anxiety disorder 7 (GAD7) and Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) scales respectively. Results: Risk of post-withdrawal relapsed seizures increased with; history of status epilepticus (p=0.002), focal seizures (p=0.005), late remission of initial epileptic seizures (p=0.002), delay of ASD therapy (p<0.001), Poly-therapy (p<0.001), post-withdrawal epileptiform EEG (p<0.001), high NHS3,GAD7, NDDI-E scores (p<0.001) Conclusion: Risk of relapsing seizures after ASDs withdrawal during the first year was 60%. The decision to withdraw ASDs necessitates individual evaluation of each case with accurate assessment of risk factors associating with relapsed seizures. Keywords: Relapsed seizures, Predictors, Drug withdrawal
- Open Access
- 15 June 2022
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 58 (1) , 1-7
The effect of hypocalcemia on motor symptoms of Parkinson’s disease
- 15 June 2022
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 58 (1) , 1-7
Open AccessThe effect of hypocalcemia on motor symptoms of Parkinson’s disease
- 1 March 2022
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
- Vol. 28 (2) , 379-388
Migraine and Subclinical Hypothyroidism: A Possible Co-morbidity
Introduction: Migraine and subclinical hypothyroidism (SCH) are common medical diseases, both share similar pathophysiological changes. Aims: To estimate the frequency of SCH among migraine patients and to evaluate the impact of SCH on migraine as regard severity and disability. Methods: Using a case control strategy, 130 patients with migraine and 130 healthy control subjects were recruited. Measurement of thyroid hormones levels was done for all the participants. Numerical Pain Rating Scale (NPRS) was used to detect the intensity of pain. Migraine severity and disability in different activity domains were assessed by Migraine Severity Scale (MIGSEV) and Headache Disability Index (HDI), respectively and patients' response to migraine treatment was evaluated by Headache Under-Response to Treatment Questionnaire (HURT). Results: The frequency of SCH was significantly higher among migraine patients than control subjects (p=0.002; OR=2.89; at 95% CI). Intensity of pain and migraine disability were significantly high in migraine patients with SCH when compared to migraine patients without SCH (p=.0001, p= 0.01, respectively). Most of migraine patients with SCH had grades II and III of MIGSEV scale (p=0.01, p= 0.04). The control of migraine was not good in 44.8% of the group with SCH versus 19.4% of the group without SCH (p=0.005). Conclusions: Subclinical hypothyroidism is more frequent among patients with migraine in respect to control subjects. Moreover, SCH has negative impacts on migraine regarding severity and disability.
- 1 March 2022
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
- Vol. 28 (2) , 379-388
Migraine and Subclinical Hypothyroidism: A Possible Co-morbidity
Introduction: Migraine and subclinical hypothyroidism (SCH) are common medical diseases, both share similar pathophysiological changes. Aims: To estimate the frequency of SCH among migraine patients and to evaluate the impact of SCH on migraine as regard severity and disability. Methods: Using a case control strategy, 130 patients with migraine and 130 healthy control subjects were recruited. Measurement of thyroid hormones levels was done for all the participants. Numerical Pain Rating Scale (NPRS) was used to detect the intensity of pain. Migraine severity and disability in different activity domains were assessed by Migraine Severity Scale (MIGSEV) and Headache Disability Index (HDI), respectively and patients' response to migraine treatment was evaluated by Headache Under-Response to Treatment Questionnaire (HURT). Results: The frequency of SCH was significantly higher among migraine patients than control subjects (p=0.002; OR=2.89; at 95% CI). Intensity of pain and migraine disability were significantly high in migraine patients with SCH when compared to migraine patients without SCH (p=.0001, p= 0.01, respectively). Most of migraine patients with SCH had grades II and III of MIGSEV scale (p=0.01, p= 0.04). The control of migraine was not good in 44.8% of the group with SCH versus 19.4% of the group without SCH (p=0.005). Conclusions: Subclinical hypothyroidism is more frequent among patients with migraine in respect to control subjects. Moreover, SCH has negative impacts on migraine regarding severity and disability.
- 26 October 2021
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Assessment of Serum Calcium Level in Relation to Cognitive Dysfunction in Patients with Parkinson's disease
Introduction; Cognitive impairment is among the most disabling features of Parkinson’s disease (PD). Calcium has been postulated to play a role in PD. Aims; To evaluate the relation between serum calcium disturbances and deterioration of cognitive function in patients with PD. Methods; A case control study was conducted on 30 patients with clinically definite idiopathic PD diagnosed according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson’s disease and 30 healthy control subjects. The cognitive function was assessed in the participants using Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) , Rey Auditory verbal learning test (RAVLT) and Visual reproduction subtest of the Wechsler Memory Scale Revised (VR WMS-R).Serum calcium level was measured for all the participants. Results; The PD patients were found to have a significantly lower level of serum total and ionized calcium than control subjects (P < 0.05). The PD patients with hypocalcaemia had a significant impairment of cognitive function in comparison with PD patients with normal calcium level regarding to the scores of both groups in MoCA, RAVLT and VR WMS-R scales ( P = 0.001 in all parameters) and MMSE (P = 0.002) There were significant positive correlations between serum calcium level and PD patients' scores of MoCA, MMSE, RAVLT and VR WMS-R (P = 0.001 in all parameters). Conclusion; The disturbances of serum calcium level especially low serum calcium level could deteriorate cognitive function in PD patients.
- 26 October 2021
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Assessment of Serum Calcium Level in Relation to Cognitive Dysfunction in Patients with Parkinson's disease
Introduction; Cognitive impairment is among the most disabling features of Parkinson’s disease (PD). Calcium has been postulated to play a role in PD. Aims; To evaluate the relation between serum calcium disturbances and deterioration of cognitive function in patients with PD. Methods; A case control study was conducted on 30 patients with clinically definite idiopathic PD diagnosed according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson’s disease and 30 healthy control subjects. The cognitive function was assessed in the participants using Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) , Rey Auditory verbal learning test (RAVLT) and Visual reproduction subtest of the Wechsler Memory Scale Revised (VR WMS-R).Serum calcium level was measured for all the participants. Results; The PD patients were found to have a significantly lower level of serum total and ionized calcium than control subjects (P < 0.05). The PD patients with hypocalcaemia had a significant impairment of cognitive function in comparison with PD patients with normal calcium level regarding to the scores of both groups in MoCA, RAVLT and VR WMS-R scales ( P = 0.001 in all parameters) and MMSE (P = 0.002) There were significant positive correlations between serum calcium level and PD patients' scores of MoCA, MMSE, RAVLT and VR WMS-R (P = 0.001 in all parameters). Conclusion; The disturbances of serum calcium level especially low serum calcium level could deteriorate cognitive function in PD patients.